NextCell Pharma AB

65G

Company Profile

  • Business description

    NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

  • Contact

    Karolinska Institutet Science Park
    Halsovagen 7
    Huddinge14157
    SWE

    T: +46 87355595

    http://www.nextcellpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 August 2025

    Employees

    24

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,829.3051.400.59%
CAC 407,878.46111.751.44%
DAX 4024,549.56342.651.42%
Dow JONES (US)44,458.30217.540.49%
FTSE 1008,867.0212.840.15%
HKSE23,892.32255.75-1.06%
NASDAQ20,611.34192.870.94%
Nikkei 22539,611.24210.04-0.53%
NZX 50 Index12,774.485.870.05%
S&P 5006,263.2637.740.61%
S&P/ASX 2008,590.8052.200.61%
SSE Composite Index3,490.912.14-0.06%

Market Movers